Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE

Cancer Genetics

Volumn 205, Issue 11, 2012, Pages 552-562

  Lai, Shan Shan ^a   Xue, Bin ^a   Yang, Yang ^a   Zhao, Li ^a   Chu, Chao Shun ^b   Hao, Jia Yin ^a   Wen, Chuan Jun ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Metastasis; NRAGE; Ror2

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; MELANOMA ANTIGEN; NEUROTROPHIN RECEPTOR INTERACTING MAGE HOMOLOGUE; PROTEIN TYROSINE KINASE; ROR2 PROTEIN; SRC KINASE; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; MELANOMA B16; MELANOMA CELL; METASTASIS INHIBITION; MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SERINE THREONINE RICH 1 DOMAIN; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; FOCAL ADHESION KINASE 1; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOPRECIPITATION; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

MURINAE;

EID: 84869416805     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.09.002     Document Type: Article

References (53)

1. Kim C., Forrester W.C. Functional analysis of the domains of the C elegans Ror receptor tyrosine kinase CAM-1. Dev Biol 2003, 264:376-390.
2. Al-Shawi R., Ashton S.V., Underwood C., et al. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev Genes Evol 2001, 211:161-171.
3. Afzal A.R., Jeffery S. One gene, two phenotypes: ROR2 mutations in autosomal recessive Robinow syndrome and autosomal dominant brachydactyly type B. Hum Mutat 2003, 22:1-11.
4. Billiard J., Way D.S., Seestaller-Wehr L.M., et al. The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells. Mol Endocrinol 2005, 19:90-101.
5. Liu Y., Bhat R.A., Seestaller-Wehr L.M., et al. The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation. Mol Endocrinol 2007, 21:376-387.
6. Yamamoto H., Yoo S.K., Nishita M., et al. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Genes Cells 2007, 12:1215-1223.
7. Matsuda T., Suzuki H., Oishi I., et al. The receptor tyrosine kinase Ror2 associates with the melanoma-associated antigen (MAGE) family protein Dlxin-1 and regulates its intracellular distribution. J Biol Chem 2003, 278:29057-29064.
8. Salehi A.H., Roux P.P., Kubu C.J., et al. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 2000, 27:279-288.
9. Bertrand M.J.M., Kenchappa R.S., Andrieu D., et al. NRAGE, a p75NTR adaptor protein, is required for developmental apoptosis in vivo. Cell Death and Differentiation 2008, 15:1921-1929.
10. Oishi I., Suzuki H., Onishi N., et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 2003, 8:645-654.
11. Nishita M., Yoo S.K., Nomachi A., et al. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol 2006, 175:555-562.
12. Nomachi A., Nishita M., Inaba D., et al. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem 2008, 283:27973-27981.
13. O'Connell M.P., Fiori J.L., Xu M., et al. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 2010, 29:34-44.
14. Ren D.Y., Minami Y., Nishita M. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Genes Cells 2011, 16:304-315.
15. Xue B., Wen C.J., Shi Y.H., et al. Human NRAGE disrupts E-cadherin/beta-catenin regulated homotypic cell-cell adhesion. Biochem Bioph Res Co 2005, 336:247-251.
16. Chu C.S., Xue B., Tu C., et al. NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo. Cancer Lett 2007, 250:268-275.
17. He T.C., Zhou S., da Costa L.T., et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998, 95:2509-2514.
18. Poste G., Doll J., Brown A.E., et al. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases. Cancer Res 1982, 42:2770-2778.
19. de Heer P., Koudijs M.M., van de Velde C.J.H., et al. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation. Ejso-Eur J Surg Onc 2008, 34:1253-1261.
20. Schlaepfer D.D., Mitra S.K. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004, 14:92-101.
21. Luo Y., Liang F., Zhang Z.Y. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. Biochemistry 2009, 48:1838-1846.
22. Palumbo R., De Marchis F., Pusterla T., et al. Src family kinases are necessary for cell migration induced by extracellular HMGB1. J Leukoc Biol 2009, 86:617-623.
23. Sun G., Sharma A.K., Budde R.J. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation. Oncogene 1998, 17:1587-1595.
24. Tripathi B.K., Zelenka P.S. Cdk5-dependent regulation of Rho activity, cytoskeletal contraction, and epithelial cell migration via suppression of Src and p190RhoGAP. Mol Cell Biol 2009, 29:6488-6499.
25. Van Slambrouck S., Grijelmo C., De Wever O., et al. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha 1-integrins during colon cancer cell invasion. Int J Oncol 2007, 31:1501-1508.
26. Pohorelic B., Singh R., Parkin S., et al. Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment. Breast Cancer Res Treat 2012, 133:201-214.
27. Yu H.S., Lin T.H., Tang C.H. Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCdelta/c-Src dependent signaling pathway. Prostate 2012, 10.1002/pros.22544.
28. Zuo J.H., Zhu W., Li M.Y., et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 2011, 112:2508-2517.
29. Maier H.J., Schmidt-Strassburger U., Huber M.A., et al. NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett 2010, 295:214-228.
30. Masugi Y., Yamazaki K., Hibi T., et al. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer. Hum Pathol 2010, 41:1061-1068.
31. Lambropoulou M., Tamiolakis D., Venizelos I., et al. Induction of hepatic haematopoiesis with fibronectin expression by EMT stromal cells during the second trimester of development. Clin Exp Med 2007, 7:115-121.
32. Rochira J.A., Matluk N.N., Adams T.L., et al. A small peptide modeled after the NRAGE repeat domain inhibits XIAP-TAB1-TAK1 signaling for NF-kappaB activation and apoptosis in P19 cells. Plos One 2011, 6:e20659.
33. Barrett G.L., Greferath U., Barker P.A., et al. Co-expression of the P75 neurotrophin receptor and neurotrophin receptor-interacting melanoma antigen homolog in the mature rat brain. Neuroscience 2005, 133:381-392.
34. Bragason B.T., Palsdottir A. Interaction of PrP with NRAGE, a protein involved in neuronal apoptosis. Mol Cell Neurosci 2005, 29:232-244.
35. Kendall S.E., Goldhawk D.E., Kubu C., et al. Expression analysis of a novel p75(NTR) signaling protein, which regulates cell cycle progression and apoptosis. Mech Dev 2002, 117:187-200.
36. Nikopoulos G.N., Martins J.F., Adams T.L., et al. NRAGE: a potential rheostat during branching morphogenesis. Mech Dev 2009, 126:337-349.
37. Wu W., Sun Z., Wu J., et al. Trihydrophobin 1 phosphorylation by c-Src regulates MAPK/ERK signaling and cell migration. Plos One 2012, 7:e29920.
38. Masiakowski P., Carroll R.D. A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 1992, 267:26181-26190.
39. Saldanha J., Singh J., Mahadevan D. Identification of a Frizzled-like cysteine rich domain in the extracellular region of developmental receptor tyrosine kinases. Protein Sci 1998, 7:1632-1635.
40. Wu X., Zeng H., Zhang X., et al. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 2004, 164:2039-2054.
41. Akbarzadeh S., Wheldon L.M., Sweet S.M., et al. The deleted in brachydactyly B domain of ROR2 is required for receptor activation by recruitment of Src. Plos One 2008, 3:e1873.
42. Abdel-Hamid N.M. Premalignant variations in extracellular matrix composition in chemically induced hepatocellular carcinoma in rats. J Membr Biol 2009, 230:155-162.
43. Oldridge M., Fortuna A.M., Maringa M., et al. Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nat Genet 2000, 24:275-278.
44. Enomoto M., Hayakawa S., Itsukushima S., et al. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 2009, 28:3197-3208.
45. Tateno M., Nishida Y., Adachi-Yamada T. Regulation of JNK by Src during Drosophila development. Science 2000, 287:324-327.
46. Kraus S., Benard O., Naor Z., et al. c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells. J Biol Chem 2003, 278:32618-32630.
47. Crossthwaite A.J., Valli H., Williams R.J. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones. J Neurochem 2004, 88:1127-1139.
48. Yoshizumi M., Abe J., Haendeler J., et al. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 2000, 275:11706-11712.
49. Lee J.M., Dedhar S., Kalluri R., et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981.
50. Thiery J.P., Acloque H., Huang R.Y., et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
51. Bjorklund M., Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005, 1755:37-69.
52. Wright T.M., Brannon A.R., Gordan J.D., et al. Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene 2009, 28:2513-2523.
53. Yamamoto H., Oue N., Sato A., et al. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010, 29:2036-2046.